Burden of Gynecological Cancers in India
Article Sidebar
Main Article Content
Abstract
Gynecological cancers contribute to a high epidemiological and economic burden on women and the healthcare system of the country. Breast cancer is the most common cancer in females. Every year there are around five lakh new gynecological cancers worldwide, while more than one lakh of these are diagnosed in India only. Cervical cancer remains the most common gynecological cancer in India. The estimated cancer incidence for the year 2022 is breast (33.0%), cervix (12.3%), ovary (6.5%), and corpus uteri (3.7%) among the top 10 leading sites of cancers in India. Ovarian cancer remains the main cause of cancer-related death in women. The main causes of poor survival are less awareness and late reporting at advanced stages. To overcome the challenge of the rising gynecological cancer burden in India, we need to have accurate data on cancer prevalence and the wider implementation of preventive programs. The prevention, early diagnosis, and treatment of cervical cancer can result in reducing the overall gynecological cancer burden in India.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Under Creative Commons the Authors retain ownership of the copyright for their content. The authors assign exclusive commercial re-use rights of the article to the Journal.
All open access articles published are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License as currently displayed at http://creativecommons.org/licenses/by-nc/4.0/legalcode) which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original work is properly cited.
Authors agree to the open access publication policy of the Journal.
References
Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P. Cancer incidence estimates for 2022 & projection for 2025: result from National Cancer Registry Programme, India. Indian Journal of Medical Research. 2023 Jan 11.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today. International Agency for Research on Cancer. Lyon, France. 2020.
World Health Organisation(WHO) The Global Cancer Observatory(GLOBOCAN). https://gco.iarc.fr/today/data/ factsheets/populations/356-india-fact-sheets.
Franasiak JM, Scott RT. Demographics of cancer in the reproductive age female. Cancer and fertility. 2016:11-9.
Wilson CM, Tobin S, Young RC. The exploding worldwide cancer burden. International Journal of Gynecologic Cancer. 2004 Jan 1;14(1).
Price AJ, Ndom P, Atenguena E, Mambou Nouemssi JP, Ryder RW. Cancer care challenges in developing countries. Cancer. 2012 Jul 15;118(14):3627-35.
Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best practice & research Clinical obstetrics & gynaecology. 2006 Apr 1;20(2):207-25.
Kim SG, Hahm MI, Choi KS, Seung NY, Shin HR, Park EC. The economic burden of cancer in Korea in 2002. European journal of cancer care. 2008 Mar;17(2):136-44.
Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. Journal of clinical pathology. 2002 Apr 1;55(4):244-65.
Wright Jr TC, Kuhn L. Alternative approaches to cervical cancer screening for developing countries. Best practice & research Clinical obstetrics & gynaecology. 2012 Apr 1;26(2):197-208.
Pearson JM, Feltman RS, Twiggs LB. Association of human papillomavirus with vulvar and vaginal intraepithelial disease: opportunities for prevention. Women’s Health. 2008 Mar;4(2):143-50.
Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA: a cancer journal for clinicians. 2011 May;61(3):183-203.
Parkin DM. The evolution of the population-based cancer registry. Nature Reviews Cancer. 2006 Aug 1;6(8):603-12.
ICMR-National Centre for Disease Informatics and Research(NCDIR). Report of National Cancer Registry Programme 2020. Bengaluru (India). Available from: https://ncdirindia.org/All_Reports/PBCR_Annexures/Default.aspx, accessed on June 20, 2022.
Lucas E. Cancer survival in Africa, Asia, the Caribbean and Central America. Sankaranarayanan R, Swaminathan R, editors. Lyon: International Agency for Research on Cancer; 2011.
World Health Organization (WHO). Comprehensive cervical cancer control: a guide to essential practice. Geneva, Switzerland: World Health Organization; 2014.
Nandakumar A, Kishor Rath G, Chandra Kataki A, Poonamalle Bapsy P, Gupta PC, Gangadharan P, Mahajan RC, Nath Bandyopadhyay M, Kumaraswamy, Vallikad E, Visweswara RN. Concurrent chemoradiation for cancer of the cervix: results of a multi-institutional study from the setting of a developing country (India). Journal of Global Oncology. 2015 Oct;1(1):11-22.
Shanta V, Selvaluxmy G, Swaminathan R, Shanthi P. Evolution in the management of locally advanced cervical cancer: the experience of Cancer Institute (WIA), Chennai, India. Asian Pac J Cancer Prev. 2010 Jan 1;11(4):1091-8.
Nunnery SE, Fintel AE, Jackson WC, Chandler JC, Ugwueke MO, Martin MG. Treatment disparities faced by undocumented workers from low-and middle-income countries in the United States with hematologic malignancies. Journal of the National Comprehensive Cancer Network. 2016 Apr 1;14(4):483-6.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018 Nov;68(6):394-424.
Giede KC, Kieser K, Dodge J et al: Who should operate on patients with ovarian cancer? An evidence based review. Gynaecol Oncol 2005, 99, 447-61.
Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, Patras J, Mahony BS, Andersen MR. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007 Jan 15;109(2):221-7.
Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, Trimble EL, Bodurka DC, Bristow RE, Carney M, Warren JL. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. Journal of the National Cancer Institute. 2006 Feb 1;98(3):172-80.
Chaturvedi M, Krishnan S, Das P, Sudarshan KL, Stephen S, Monesh V, Mathur P. Descriptive Epidemiology of Ovarian Cancers in India: A Report from National Cancer Registry Programme. Indian Journal of Gynecologic Oncology. 2023 Mar;21(1):25.
Consensus document for epithelial ovarian cancer. ICMR 2019
Balasubramaniam G, Sushama S, Rasika B, Mahantshetty U. Hospital-based study of endometrial cancer survival in Mumbai, India. Asian Pacific Journal of Cancer Prevention. 2013;14(2):977-80.
McMeekin DS, Yashar C, Campos SM, Zaino RJ. Corpus: Epithelial Tumors. in: Principles and Practice of Gynecologic Oncology (eds. Barakat RR, Berchuk A, Markman M, Randall M). 6th ed. Lippincott Williams & Wilkins; 2013. p. 661-714.
Cancer Today-Global cancer observatory https://gco.iarc.fr/today/home. Last accessed on 12 Oct 2018.
Biswas A, Patel F, Kumar P, Srinivasan R, Bera A, Sharma SC, Rajwanshi A. Uterine sarcoma-current management and experience from a regional cancer centre in North India. Archives of gynecology and obstetrics. 2013 Oct;288:873-82.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021 May;71(3):209-49.
Chhabra S, Bhavani M, Deshpande A. Trends of vulvar cancer. Journal of Obstetrics and Gynaecology. 2014 Feb 1;34(2):165-8.
Nandwani M, Barmon D, Begum D, Liegise H, Kataki AC. An overview of vulvar cancer: a single-center study from Northeast India. The Journal of Obstetrics and Gynecology of India. 2019 Dec;69:541-5.
Deka P, Barmon D, Shribastava S, Kataki AC, Sharma JD, Bhattacharyya M. Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study. Journal of mid-life health. 2014 Jan;5(1):10.
Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. The lancet oncology. 2003 Nov 1;4(11):670-8.